» Articles » PMID: 31207704

[Clinical Observation of Five Pediatric-type Follicular Lymphoma in Adult]

Overview
Specialty Hematology
Date 2019 Jun 18
PMID 31207704
Authors
Affiliations
Soon will be listed here.
Abstract

To investigate the characteristics in pathological diagnosis, clinical features, treatment and prognosis of adult patients with pediatric-type follicular lymphoma (PTFL) . The clinical and pathological features, laboratory examination, diagnosis and treatment, follow-up results of 5 adult PTFL patients admitted in Jiangsu Province Hospital were retrospectively analyzed, and literature review was conducted in combination with related reports. All 5 patients developed PTFL in their adulthood with a median age of 22 years old (15-33 years) . The initial inanifestation of the disease was local painless lymphadenopathy with no fever, night sweats, emaciation or other systemic B symptoms. Pathological characteristics including typical large follicular structures and high proliferation index were found. Meanwhile, additional clonal rearrangement of immunoglobulin heavy chain gene was observed. However, there was no BCL-2 expression in histochemistry as well as BCL-2 gene abnormality in fluorescence in situ hybridization among these PTFL patients. These adult PTFL patients were all in stage Ⅰ-Ⅱ of the disease. For treatment, they were only treated with local surgical excision after diagnosis while didn't receive subsequent local radiotherapy or systemic immunochemotherapy. During a median follow-up of 27 months, the 5 cases of PTFL kept in a state of sustained complete remission. Adult-onset PTFL is characterized by high pathological proliferation index, while no BCL-2 expression or BCL-2 gene abnormality. Besides, PTFL is clinically manifested as a localized disease that can achieve a quite good prognosis through local surgical intervention. The aforementioned attributes of PTFL are distinctly different from classic adult follicular lymphoma.

References
1.
Quintanilla-Martinez L, Sander B, Chan J, Xerri L, Ott G, Campo E . Indolent lymphomas in the pediatric population: follicular lymphoma, IRF4/MUM1+ lymphoma, nodal marginal zone lymphoma and chronic lymphocytic leukemia. Virchows Arch. 2015; 468(2):141-57. DOI: 10.1007/s00428-015-1855-z. View

2.
Federico M, Luminari S, Dondi A, Tucci A, Vitolo U, Rigacci L . R-CVP versus R-CHOP versus R-FM for the initial treatment of patients with advanced-stage follicular lymphoma: results of the FOLL05 trial conducted by the Fondazione Italiana Linfomi. J Clin Oncol. 2013; 31(12):1506-13. DOI: 10.1200/JCO.2012.45.0866. View

3.
Agrawal R, Wang J . Pediatric follicular lymphoma: a rare clinicopathologic entity. Arch Pathol Lab Med. 2009; 133(1):142-6. DOI: 10.5858/133.1.142. View

4.
Martin-Guerrero I, Salaverria I, Burkhardt B, Szczepanowski M, Baudis M, Bens S . Recurrent loss of heterozygosity in 1p36 associated with TNFRSF14 mutations in IRF4 translocation negative pediatric follicular lymphomas. Haematologica. 2013; 98(8):1237-41. PMC: 3729904. DOI: 10.3324/haematol.2012.073916. View

5.
Swerdlow S . Pediatric follicular lymphomas, marginal zone lymphomas, and marginal zone hyperplasia. Am J Clin Pathol. 2005; 122 Suppl:S98-109. DOI: 10.1309/4BKNAKE4D7CT3C1B. View